14 Feb 2018
FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
ORC-13661 Could Be the First Medicine Approved Specifically to Prevent Hearing Loss of Patients Using Certain Antibiotics
ORC-13661 Could Be the First Medicine Approved Specifically to Prevent Hearing Loss of Patients Using Certain Antibiotics